BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31813224)

  • 1. A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy.
    Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Lerchen HG; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Org Chem; 2020 Feb; 85(3):1446-1457. PubMed ID: 31813224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Neuropeptide Y Conjugates with Maximized Carborane Loading as Promising Boron Delivery Agents for Boron Neutron Capture Therapy.
    Worm DJ; Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Med Chem; 2020 Mar; 63(5):2358-2371. PubMed ID: 31589041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A stable meta-carborane enables the generation of boron-rich peptide agonists targeting the ghrelin receptor.
    Worm DJ; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Koebberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Pept Sci; 2018 Oct; 24(10):e3119. PubMed ID: 30168238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carborane-FAPI conjugate: A potential FAP-targeted boron agent with improved boron content.
    Zhang J; Wu Y; Lu W; Xiao Y; Liu S; Yu J
    Appl Radiat Isot; 2024 Jul; 209():111330. PubMed ID: 38657372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
    Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
    Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-targeting hyaluronic acid/fluorescent carborane complex for boron neutron capture therapy.
    Yamana K; Kawasaki R; Sanada Y; Tabata A; Bando K; Yoshikawa K; Azuma H; Sakurai Y; Masunaga SI; Suzuki M; Sugikawa K; Nagasaki T; Ikeda A
    Biochem Biophys Res Commun; 2021 Jun; 559():210-216. PubMed ID: 33957482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER-2-Targeted Boron Neutron Capture Therapy with Carborane-integrated Immunoliposomes Prepared via an Exchanging Reaction.
    Kawasaki R; Oshige A; Yamana K; Hirano H; Nishimura K; Miura Y; Yorioka R; Sanada Y; Bando K; Tabata A; Yasuhara K; Miyazaki Y; Shinoda W; Nishimura T; Azuma H; Takata T; Sakurai Y; Tanaka H; Suzuki M; Nagasaki T; Ikeda A
    Chemistry; 2023 Dec; 29(72):e202302486. PubMed ID: 37792507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-decorated carborane-TAT conjugation nanomicelles: A potential boron agent with enhanced selectivity of tumor cellular uptake.
    Quan H; Fan L; Huang Y; Xia X; He Y; Liu S; Yu J
    Colloids Surf B Biointerfaces; 2021 Aug; 204():111826. PubMed ID: 33984611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent Organic Polymer as a Carborane Carrier for Imaging-Facilitated Boron Neutron Capture Therapy.
    Shi Y; Fu Q; Li J; Liu H; Zhang Z; Liu T; Liu Z
    ACS Appl Mater Interfaces; 2020 Dec; 12(50):55564-55573. PubMed ID: 33327054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sweet Battle of the Epimers─Continued Exploration of Monosaccharide-Derived Delivery Agents for Boron Neutron Capture Therapy.
    Matović J; Bahrami K; Stockmann P; Sokka IK; Khng YC; Sarparanta M; Hey-Hawkins E; Rautio J; Ekholm FS
    Mol Pharm; 2023 Jun; 20(6):3127-3139. PubMed ID: 37134022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asialoglycoprotein receptor targeted micelles containing carborane clusters for effective boron neutron capture therapy of hepatocellular carcinoma.
    Zhang T; Li G; Li S; Wang Z; He D; Wang Y; Zhang J; Li J; Bai Z; Zhang Q; Liu B; Zhao Q; Liu Y; Zhang H
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110397. PubMed ID: 31357127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carborane bearing pullulan nanogel-boron oxide nanoparticle hybrid for boron neutron capture therapy.
    Kawasaki R; Hirano H; Yamana K; Isozaki H; Kawamura S; Sanada Y; Bando K; Tabata A; Yoshikawa K; Azuma H; Takata T; Tanaka H; Sakurai Y; Suzuki M; Tarutani N; Katagiri K; Sawada SI; Sasaki Y; Akiyoshi K; Nagasaki T; Ikeda A
    Nanomedicine; 2023 Apr; 49():102659. PubMed ID: 36822335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and stabilization of a highly selective gastrin-releasing peptide receptor agonist.
    Hoppenz P; Els-Heindl S; Beck-Sickinger AG
    J Pept Sci; 2019 Dec; 25(12):e3224. PubMed ID: 31743956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a Tumor-Targeting Oligosaccharide Nanosystem in BNCT on an Orthotopic Hepatocellular Carcinoma Model.
    Yang Q; Dai Q; Bao X; Zhou Y; Lu Y; Zhong H; Wu L; Guo Y; Liu L; Tan X; Xia Y; Han M; Wei Q
    Mol Pharm; 2023 Feb; 20(2):1025-1038. PubMed ID: 36571795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.
    Kreimann EL; Miura M; Itoiz ME; Heber E; Garavaglia RN; Batistoni D; Rebagliati RJ; Roberti MJ; Micca PL; Coderre JA; Schwint AE
    Arch Oral Biol; 2003 Mar; 48(3):223-32. PubMed ID: 12648560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuning a modular system - synthesis and characterisation of a boron-rich s-triazine-based carboxylic acid and amine bearing a galactopyranosyl moiety.
    Kellert M; Hoppenz P; Lönnecke P; Worm DJ; Riedl B; Koebberling J; Beck-Sickinger AG; Hey-Hawkins E
    Dalton Trans; 2020 Jan; 49(1):57-69. PubMed ID: 31808482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of cyclic RGD-boron cluster conjugates to develop tumor-selective boron carriers for boron neutron capture therapy.
    Kimura S; Masunaga S; Harada T; Kawamura Y; Ueda S; Okuda K; Nagasawa H
    Bioorg Med Chem; 2011 Mar; 19(5):1721-8. PubMed ID: 21315608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trivalent galactosyl-functionalized mesoporous silica nanoparticles as a target-specific delivery system for boron neutron capture therapy.
    Lai CH; Lai NC; Chuang YJ; Chou FI; Yang CM; Lin CC
    Nanoscale; 2013 Oct; 5(19):9412-8. PubMed ID: 23958787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome formulations of o-carborane for the boron neutron capture therapy of cancer.
    Olusanya TOB; Calabrese G; Fatouros DG; Tsibouklis J; Smith JR
    Biophys Chem; 2019 Apr; 247():25-33. PubMed ID: 30797076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphiphilic Polycarbonates from Carborane-Installed Cyclic Carbonates as Potential Agents for Boron Neutron Capture Therapy.
    Xiong H; Wei X; Zhou D; Qi Y; Xie Z; Chen X; Jing X; Huang Y
    Bioconjug Chem; 2016 Sep; 27(9):2214-23. PubMed ID: 27548011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.